| Manager | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | - | 2006-12-31 | |
Gilbert Wagener
CTO | Chief Tech/Sci/R&D Officer | - | 2023-06-14 |
Hugo Brugière
CEO | Chief Executive Officer | - | 2022-12-25 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 78 | 2020-07-16 | |
James Kuo
BRD | Director/Board Member | 60 | 2022-06-15 |
| Director/Board Member | 66 | 2023-07-09 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/17/21 | Buy | Chairman | 24,038 | 0.1123% | ||
| 2/12/21 | Buy | Director | 730,994 | 4.2923% | ||
| 3/30/20 | Sell | Director | 118,022 | 0.7749% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 39 | |
| -1.36% | +4.74% | +58.34% | +119.55% | 1,144B | |
| -1.75% | +0.40% | +32.85% | +68.39% | 625B | |
| -1.96% | +0.05% | +22.58% | +95.97% | 511B | |
| +0.54% | +5.69% | +39.60% | +65.02% | 377B | |
| +0.20% | +0.85% | +69.62% | +43.80% | 366B | |
| +0.30% | +3.44% | +21.35% | +50.15% | 291B | |
| -0.03% | +2.55% | +1.12% | +24.89% | 262B | |
| -0.82% | +2.34% | +44.81% | +59.70% | 237B | |
| -2.23% | -0.13% | +23.58% | +97.71% | 194B | |
| Average | -0.69% | +6.31% | +34.87% | +69.46% | 445.32B | |
| Weighted average by Cap. | -0.96% | +6.91% | +40.16% | +80.69% |
Employees
19
Sector
Pharmaceuticals
